LEVOSIMENDAN
2-[[4-[(4R)-4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl]phenyl]hydrazinylidene]propanedinitrile
Molecular Identity
LEVOSIMENDAN
2-[[4-[(4R)-4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl]phenyl]hydrazinylidene]propanedinitrile
PubChem CID: 3033825
Levosimendan is a nitrile, a pyridazinone and a hydrazone. It has a role as a vasodilator agent, an anti-arrhythmia drug, a cardiotonic drug and an EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor.
2D Structure
Properties
C14H12N6O
Molecular Formula
280.28
Molecular Weight
g/mol
280.1073
Exact Mass
Da
2.3
XLogP
Drug-like (Lipinski: < 5)
113
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
6
H-Bond Acceptors
549
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
LEVOSIMENDAN141505-33-1Simdax(R)-Simendan(-)-OR-1259levosimendanumOR-1259Simendan, (r)-OR1259NSC-759644DTXSID9046445CHEBI:50567C6T4514L4EDTXCID70264451-cyano-N-{4-[(4R)-4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl]phenyl}methanecarbohydrazonoyl cyanide
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to LEVOSIMENDAN
Loading drug network...